All News

Pharmacist intervention is one primary way that adherence to cholesterol-lowering medications can be improved in minority neighborhoods, a recent study found.

New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.

New branded drugs, new generics.

Dennis Song, RPh, describes the steps to take when starting a compounding services business.

Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.

Anxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh.

The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.

Despite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.

A coordinated effort needs to be made to preserve the health and safety of life on earth.

Generic drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them.

What do pharmacists and teachers - and an awful lot of other people - have in common?

Biosimilars are the future of pharmacy. When they hit community pharmacy, issues that have been important in specialty settings are going to explode.

McKesson recognized some outstanding community pharmacies at this year's IdeaShare.

Pharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.

Anticoagulation briefs.

Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.

What is the pharmacist’s duty? This case history may shed some light.

FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.

Once physicians see what you can do for them, they won't want to let you go.

In 2004, Rhode Island became the first state to authorize its pharmacy board to license Canadian pharmacies to ship medications to its residents.

“Basically, everything we know will be gutted over the next three years.”

Continuous medication management pays off.

And Medicare, Medicaid, and private insurers are increasingly willing to pay.

Local HIE, regional EHR, interoperability all over the place -- get your pharmacy ready. They're practically here.

The summer months can be a time of increased activity for many people, as warmer temperatures usher in numerous outdoor events that can be more strenuous and bring us closer to nature.

Glycopyrrolate bromide is a quick-onset long-acting muscarinic antagonist bronchodilator with FDA approval for use as maintenance treatment of COPD. Seebri Neohaler is approved for use at a dose of 15.6 ug inhaled twice daily.

There is a growing group of LAMA/LABA combination therapies in development. Investigations into the risks and benefits of LAMA/LABA therapy have demonstrated benefits.

Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts.